
ACC 2026
Heart Device Matches Blood Thinners for Stroke Prevention in AFib, with Half the Bleeding
CHAMPION-AF trial: Left atrial appendage closure proves non-inferior to NOACs

CHAMPION-AF trial: Left atrial appendage closure proves non-inferior to NOACs

VESALIUS-CV subanalysis: evolocumab reduces major adverse cardiac events by 31%

Phase 2 trial of tonlamarsen in resistant hypertension: the drug’s

STEMI-DTU trial: Delayed reperfusion with LV unloading shows no significant

Long-awaited survival data from the ARTO trial have confirmed that

A multicentre randomised trial has demonstrated that perioperative combination therapy